Incidence and Risk Factors Associated With Switching Between b/tsDMARD in PsASeptember 18, 2024Psoriatic Arthritis
Apremilast Effective in Early PsA With Limited Joint InvolvementSeptember 18, 2024Psoriatic Arthritis
Rheumatology NewsTopical Tapinarof and Roflumilast for Psoriasis: Where Do they Fit In?September 10, 2024Psoriatic Arthritis
Rheumatology NewsUstekinumab’s ‘Egregious’ Medicare Part B and D Pricing Differences Led to Federal InterventionAugust 30, 2024Business of MedicinePsoriatic Arthritis
Rheumatology NewsNew Associations Identified Between IBD and Extraintestinal ManifestationsAugust 29, 2024Psoriatic ArthritisAnkylosing spondylitis
Rheumatology NewsTYK2 Inhibitor Effective for Psoriasis in Phase 2 StudyAugust 27, 2024Psoriatic Arthritis
Rheumatology NewsPatients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, TooAugust 23, 2024Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Rheumatology NewsDo You Have Patients With JAKne — JAK Inhibitor–Associated Acne? Here’s What to KnowAugust 22, 2024Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Genetic Study Reveals Increased Mutual Risk Between PsA and Ulcerative ColitisAugust 16, 2024Psoriatic Arthritis
Ultrasound Can Detect Disease Activity in PsA Patients Apparently Within Treatment TargetAugust 16, 2024Psoriatic Arthritis
Bimekizumab Outperforms Ustekinumab for PsA in a Matching-Adjusted Indirect ComparisonAugust 16, 2024Psoriatic Arthritis
